Chronic disease is the term applied to any medical condition that is persistent, recurring, or long-lasting — formally defined by the U.S. Centers for Disease Control and Prevention as lasting one year or more and requiring ongoing medical care or limiting daily activity. The category is broad by design: it encompasses cardiovascular disease, type 2 diabetes, obesity, chronic kidney disease, COPD, autoimmune conditions such as rheumatoid arthritis and Hashimoto’s thyroiditis, inflammatory bowel disease, and metabolic syndrome, among many others. What unites these diverse diagnoses is not the organ system affected, but the shared biological dysfunction driving them.

At the molecular level, most chronic diseases arise from and are sustained by a constellation of interacting imbalances. Chronic low-grade systemic inflammation — characterised by persistently elevated cytokines including interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-α), and C-reactive protein — maintains the immune system in a state of constant activation that progressively damages tissues, impairs insulin signalling, accelerates cellular ageing, and promotes endothelial dysfunction. Mitochondrial dysfunction reduces the efficiency with which cells convert oxygen and nutrients into adenosine triphosphate (ATP), producing the overwhelming fatigue that characterises so many chronic conditions while generating reactive oxygen species that further fuel oxidative stress. Gut microbiome dysbiosis — disruption of the trillions of bacteria, fungi, and archaea lining the intestinal tract — compromises barrier integrity, allowing bacterial lipopolysaccharides (endotoxins) to enter systemic circulation and trigger immune activation. The hypothalamic-pituitary-adrenal (HPA) axis, the body’s central stress-response system, becomes dysregulated from chronic psychosocial stress, producing cortisol patterns that promote insulin resistance, suppress immune function, and accelerate inflammatory signalling.

Conventional medicine approaches chronic disease primarily through pharmaceutical management: statins for cardiovascular risk, metformin and insulin for diabetes, biologics for autoimmune conditions, antihypertensives for elevated blood pressure. These interventions are often necessary and life-saving, but they address downstream symptoms rather than the upstream drivers sustaining the disease process. Functional medicine, as practised at Patients Medical in New York City, takes a systematically different approach: identifying through advanced laboratory testing which specific biological imbalances are present in each individual — and correcting those imbalances through nutrition, targeted nutraceuticals, hormonal optimisation, gut restoration, and lifestyle medicine. This does not mean rejecting conventional care; it means complementing it with a root-cause layer that conventional medicine, constrained by appointment length and the diagnostic code system, rarely has time to explore.

Chronic disease affects approximately 133 million Americans — nearly half the population — and accounts for 90 percent of the nation’s $4.5 trillion annual healthcare expenditure. Seven of the ten leading causes of death in the United States are chronic diseases. Yet the CDC estimates that 80 percent of chronic disease is preventable through lifestyle factors alone — a statistic that underscores both the scale of the problem and the extraordinary power of addressing root causes rather than simply managing symptoms.